These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 2562952

  • 1. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S, Adler L, Angrist B, Peselow E, Rotrosen J.
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [Abstract] [Full Text] [Related]

  • 2. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR, Liddle PF, Curson DA, Patel M.
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract] [Full Text] [Related]

  • 3. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H, Hunt JI, Vitiello B, Simpson GM.
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [Abstract] [Full Text] [Related]

  • 4. Vulnerability to tardive dyskinesia.
    Wolf ME, DeWolfe AS, Ryan JJ, Lips O, Mosnaim AD.
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [Abstract] [Full Text] [Related]

  • 5. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD.
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [Abstract] [Full Text] [Related]

  • 6. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):761-4. PubMed ID: 18201810
    [Abstract] [Full Text] [Related]

  • 7. Tardive dyskinesia, impaired recall, and informed consent.
    Ganguli R, Raghu U.
    J Clin Psychiatry; 1985 Oct 01; 46(10):434-5. PubMed ID: 2864333
    [Abstract] [Full Text] [Related]

  • 8. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I, Langlois-Thery S, Dollfus S, Petit M.
    Encephale; 1997 Oct 01; 23(4):267-72. PubMed ID: 9417392
    [Abstract] [Full Text] [Related]

  • 9. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H, Bourgeois M.
    Encephale; 1996 Jun 01; 22 Spec No 2():45-7. PubMed ID: 8767042
    [Abstract] [Full Text] [Related]

  • 10. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC, Honer WG.
    J Clin Psychopharmacol; 1994 Dec 01; 14(6):430-1. PubMed ID: 7533794
    [No Abstract] [Full Text] [Related]

  • 11. Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.
    Stedman TJ, Whiteford HA, Eyles D, Welham JL, Pond SM.
    J Clin Psychopharmacol; 1991 Feb 01; 11(1):43-7. PubMed ID: 1674950
    [Abstract] [Full Text] [Related]

  • 12. Effects of adjunctive verapamil administration in chronic schizophrenic patients.
    Bartko G, Horvath S, Zador G, Frecska E.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Feb 01; 15(3):343-9. PubMed ID: 1677775
    [Abstract] [Full Text] [Related]

  • 13. Long term treatment of tardive dyskinesia.
    Jus A, Jus K, Fontaine P.
    J Clin Psychiatry; 1979 Feb 01; 40(2):72-7. PubMed ID: 33156
    [Abstract] [Full Text] [Related]

  • 14. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH.
    Mov Disord; 1994 May 01; 9(3):321-4. PubMed ID: 7913739
    [Abstract] [Full Text] [Related]

  • 15. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE, Coyne L.
    Brain Cogn; 1993 Sep 01; 23(1):28-39. PubMed ID: 8105820
    [Abstract] [Full Text] [Related]

  • 16. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia].
    Kaiser W.
    Nervenarzt; 1989 Apr 01; 60(4):206-12. PubMed ID: 2566936
    [No Abstract] [Full Text] [Related]

  • 17. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S, Dollfus S, Lesieur P, Petit M.
    Encephale; 1994 Apr 01; 20(5):487-93. PubMed ID: 7828511
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME, DeWolfe AS, Mosnaim AD.
    Hillside J Clin Psychiatry; 1987 Apr 01; 9(1):3-11. PubMed ID: 2888712
    [Abstract] [Full Text] [Related]

  • 19. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG, Vinogradov S, Prosser E, Kaplan J, Berger PA, Hollister LE.
    Psychopharmacol Bull; 1986 Apr 01; 22(3):897-9. PubMed ID: 2879311
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB, Caligiuri MP.
    J Clin Psychiatry; 1996 Apr 01; 57(4):167-73. PubMed ID: 8601552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.